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Abstract
Background: Vitamin D homeostasis may play a critical role in glucose metabolism. Little is known on vitamin D
deficiency and its association with diabetes in countries of the Arabia Gulf where the population is experiencing a
rapid increase in the incidence of diabetes.
Methods: In a cross-sectional study of 960 adults enrolled in the first National Nutrition Survey of the State of
Kuwait (NNSSK), we examined vitamin D status in association with the prevalence of diabetes and prediabetes.
Vitamin D status was measured by serum levels of 25-hydroxyvitamin D (25(OH)D). Prevalences of diabetes and
prediabetes were determined based on fasting glucose and HbA1C levels.
Results: The median level of serum 25(OH)D in Kuwaiti adults was 13.8 ng/ml. Approximately 56 % of the Kuwaiti adults
had vitamin D inadequacy (25(OH)D = 12–19.9 ng/ml), and 27 % had vitamin D deficiency (25(OH)D < 12 ng/ml). The
prevalences of prediabetes and diabetes were 40 and 27 %, respectively. Vitamin D inadequacy (OR = 1.7, 95 % CI: 1.0–2.9)
and deficiency (OR =2.0, 95 % CI: 1.1–3.3) was each associated with about two-fold increased odds of prediabetes
compared to sufficient vitamin D status (25(OH)D ≥20 ng/ml). Vitamin D inadequacy (OR =2.1, 95 % CI: 1.2–3.7) and
deficiency (OR =2.0, 95 % CI: 1.1–3.9) were also associated with two-fold increased odds of diabetes.
Conclusions: Data from Kuwaiti’s first national nutritional survey suggests a very high prevalence of vitamin D deficiency
in Kuwaiti adults. Associations of low vitamin D status and high prevalence of diabetes point to the need of continuous
monitoring of vitamin D status and further evaluating potential health consequences in this high-risk population.
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Background
The incidence of diabetes and other metabolic disorders is
increasing at an alarming rate in countries of the Arabian
Gulf, possibly due to dramatic changes in lifestyle and
food intake patterns since the discovery of oil in the 1950s
[1, 2]. The National Nutrition Surveillance System data
from 1998 to 2009 revealed that the prevalence of obesity
reached 77 % in Kuwaiti adults [3]. The prevalence of
diabetes and metabolic syndrome is also higher in the
State of Kuwait than in many developed countries, placing
“a wake-up call for public health intervention” [2, 4].
A growing literature suggests that vitamin D homeo-
stasis may play a role in the etiology of type 1 and type 2
diabetes [5–7]. Animal and cell studies discovered that
vitamin D affects insulin secretion through binding of its
active form to vitamin D receptors in pancreatic beta cells
[8–11]. Vitamin D also affects insulin resistance by stimu-
lating the expression of insulin receptors [12], or indirectly
by regulating calcium homeostasis [13]. Despite proposed
biological mechanisms, observational studies and clinical
trials in humans did not provide consistent evidence re-
garding the association between vitamin D status and dia-
betes [7, 14, 15]. Furthermore, most studies were
conducted in populations of North America and few stud-
ies investigated vitamin D deficiency in association with
diabetes in other racial/ethnic groups for whom the
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vitamin D status could be substantially lower than that in
non-Hispanic whites [16].
In Middle East, despite ample sunshine, vitamin D
deficiency is common due to cultural practice and dark
skin color [17]. Few studies from Middle East have ex-
amined the association between vitamin D status and
diabetes [18–20]. In particular, evidence is lacking from
a nationally representative sample of Middle East popu-
lation. Here we report findings from the first national
survey in Kuwaiti adults of vitamin D status and its as-
sociation with the prevalence of diabetes.
Methods
Study participants
Kuwait Institute for Scientific Research in association
with the Ministry of Health in Kuwait conducted a
National Nutrition Survey of the State of Kuwait
(NNSSK) between July 2008 and November 2009 to as-
sess the nutrition status and the prevalence of major
nutrition-related chronic diseases in the Kuwaiti popula-
tion [2, 4]. The NNSSK is a household based cluster sur-
vey. Specifically, a stratified probability cluster sampling
method was used to obtain a representative national sam-
ple of Kuwaiti households from 82 clusters distributed
among the six governorates of Kuwait in proportion to
population size. Initially, 1,693 households and 7,547 se-
lected household members gave consent to participate in
the survey. Of those who consented, 545 households with
a total of 1,830 household members (48 % males and 52 %
females) responded to the questionnaire based interviews
conducted at seven primary health care clinics of the
Ministry of Health located at various districts of Kuwait.
Structured questionnaires were administered to survey
subjects to collect data on socioeconomic status, medical
history and risk behaviors such as smoking and physical
activity. Dietary intake was assessed by a single 24-h diet
recall. Subjects were measured for weight, height, and
blood pressures. Fasting blood samples were collected to
assess biomarkers for nutrition intake and chronic
diseases. Among all survey participants, 1,021 were adults
age ≥20 years old. For the current analysis, 960 (94.0 %)
adults who had blood measurement of vitamin D were in-
cluded as study participants.
The study has been approved by the institutional review
boards of Tufts University and Kuwait Institute for
Scientific Research.
Vitamin D status
Serum concentration of 25-hydroxyvitamin D (25(OH)D)
was assessed for vitamin D status. Fasting blood samples
were collected by qualified phlebotomists and transported
to the Sabah Hospital National Reference Laboratory for
processing, storage and analysis. Serum 25(OH)D concen-
tration was analyzed on a Cobas e601 immunoassay
analyzer (Roche Diagnostics, USA) using manufacturer’s
kit. The kit is based on the electrochemiluminescence
principle, using streptavidin coated paramagnetic micro-
particles as universal solid phase reagent, and biotin
bound ligand and Ruthenium Bipyridyl (Ru(bpy)3
2+ complex
as the label. The reagent kits are pre-calibrated and the
master curve is readjusted before each batch of assay using
a 2-point calibrator set provided in the kit. Manufacturer’s
control sera (Preci-Control, Roche Diagnostics) were used
as internal control and Bio-Rad EQAS and Randox Inter-
national Quality Assurance Scheme were used for external
quality assurance. The serum sample was incubated with
Biotin –vitamin D and polyclonal anti-vitamin D3 anti-
body-(Ru(bpy)3
2+ complex. Solid phase is added and after
further incubation, the bound complex is captured and
washed and signal generated. The assay was standardized
against LC-MS/MS method. The inter-assay CV was 5–8 %
and the assay range was 4–100 ng/ml.
Prevalence of diabetes and prediabetes
Diabetes and prediabetes were defined based on fasting
glucose and hemoglobin A1c (HbA1C) levels and self-
reported diagnosis of diabetes or use of medications to con-
trol diabetes, according to the current diagnosis criteria
published by the American Diabetes Association (ADA) in
2012 [21]. Specifically, a subject was defined as having
diabetes if fasting glucose ≥7.0 mmol/L or HbA1C ≥
6.5 %, or if a subject reported a physician’s diagnosis of
diabetes or use of medications to control diabetes. A
subject was defined as having prediabetes if fasting
glucose = 5.6–6.9 mmol/L or HbA1C = 5.7–6.4 %. Fast-
ing glucose was analyzed on Dade-Behrin (Siemens) Di-
mension RxL automated clinical chemistry analyzer,
using the manufacturer’s kit. Bi-level internal quality con-
trol materials were run in the beginning, middle and end
of the batch. Bio-Rad external Quality Assurance scheme
provided external quality assurance. Hexokinase-glucose–
6-phosphate dehydrogenase method was used by the kit.
The inter-assay CV was 1.5–3.5 % and the assay range
was 0–27.8 mmol/L. Hemoglobin A1C was measured on
Roche Cobas Integra 400. The blood was hemolysed auto-
matically at low osmotic pressure. Calibration was done
using a synthetic N-terminal Hemogolobin A1c polypep-
tide. The non-linear standard curve was transformed by
using logit-log plot. The inter-assay CV was 2.5 %, and the
assay range was 1.4-47umol/L (24–758 ml/L).
Statistical analysis
We first evaluated characteristics of the study participants
by vitamin D status and by diabetes status. Vitamin D
status was categorized into deficiency (<12 ng/ml), inad-
equacy (12–19.9 ng/ml) or sufficiency (≥20 ng/ml) based
on serum concentration of 25(OH)D according to the cut
off values defined in the Dietary Reference Intakes
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released by the Institute of Medicine in the United States
[22, 23]. Differences in continuous variables were tested
using Analysis of Variance (ANOVA), and differences in
categorical variables were tested using a Chi-square test.
Participants were considered to be physically active if they
self-reported moderate physical activity ≥150 min/week or
strenuous physical activity ≥75 min/week and to be seden-
tary otherwise [24]. Body mass index (BMI) was calculated
based on weight and height using the standard formula,
i.e., BMI = weight (kg)/height (m)2. Weight status was
categorized as underweight if BMI < 18.5 kg/m2, nor-
mal weight if BMI =18.5–24.9 kg/m2, overweight if
BMI = 25–29.9 kg/ m2, and obese if BMI ≥ 30 kg/m2.
Because only 1.1 % of the Kuwaiti adults were underweight,
they were combined into a single group with those with
normal weight. For dietary intake of vitamin D and calcium,
we excluded 7 participants who reported extreme total
energy intake. Extreme energy intake was defined as the
log-transformed total energy intake >mean + 3 × standard
deviation or <mean – 3 × standard deviation. After adjust-
ing for total energy intake, dietary intake of vitamin D and
calcium was categorized into low and high intake group
based on the median. Because dose was not captured for
vitamin supplements, supplemental use of vitamin D and
calcium was categorized into users and nonusers. Season
was categorized into spring (Ferburary 16–May 20), sum-
mer (May 21–Novemer 4), fall (November 5–December 5)
and winter (December 6–Ferburary 15). Fall and winter
seasons were combined into one group because of similar
vitamin D concentrations and short duration of fall season.
The association between vitamin D status and diabetes
was examined using multinomial logistic regression
models. We first compared the prevalence odds of predi-
abetes and diabetes among participants with different
vitamin D status. Participants with sufficient vitamin D
status (≥20 ng/ml) were treated as the reference group.
Odds ratios (PORs) and 95 % confidence intervals (CIs)
were first adjusted for age (Model I) and then addition-
ally adjusted for a prior set of confounders including
sex, body mass index, physical activity, smoking status,
dietary intake and supplemental use of vitamin D and
calcium, and season of blood draw (Model II). We also
compared the prevalence odds of vitamin D inadequacy
and deficiency among nondiabetic, prediabetic, and diabetic
participants after adjusting for age and other confounders.
In addition, we assessed whether the associations between
vitamin D status and diabetes were modified by weight sta-
tus and dietary intake and supplemental use of vitamin D
and calcium. The significance of multiplicative interaction
was examined using the likelihood ratio test.
Sample weighting techniques and post-stratification
adjustments were made to match it to the 2005 Kuwait
census population and to reduce non-response rate or
selection biases. A raking method was used to calculate
non-response-adjusted weights producing a final set of
person weights to perform data analyses [25, 26]. Sam-
pling weights were adjusted in all analyses to account for
the complex sampling design of the survey. All statistical
analyses were performed using SAS (version 9.3; SAS
Institute, Cary, NC).
Results
Of 960 Kuwaiti adults who had serum concentration of
vitamin D, the mean age was 43.6 years (SD = 14.6), and
45.4 % were male. The mean body mass index (BMI)
was 29.9 kg/m2 (SD = 6.4), with 33.6 % being overweight
and 45.0 % being obese. Self-reported physical activity
indicated that a high proportion of Kuwaiti adults was
sedentary, with 84.1 % not meeting the 2008 Physical
Activity Guidelines for Americans (i.e. ≥150 min/week
moderate physical activity or ≥75 min/week vigorous
physical activity) [27]. About one-third of the study par-
ticipants were former (12.7 %) or current (19.6 %)
smokers. The median dietary intakes of vitamin D and
calcium from food sources were 20.9 IU/day and
342.2 mg/day respectively. The use of vitamin supple-
ment was uncommon in Kuwaiti adults: only 4.5 % of
the participants reported the use of vitamin D supple-
ment and 9.3 % reported the use of calcium supplement.
The median level of serum 25(OH)D was 13.8 ng/ml
(IQR = 7.7). Over one-third of the Kuwaiti adults (36.3 %)
had vitamin D deficiency (25(OH)D <12 ng/ml), and
nearly half (46.6 %) had vitamin D inadequacy
(25(OH)D =10–19.9 ng/ml). Participants who were
vitamin D deficient or inadequate, compared to par-
ticipants who had sufficient level of vitamin D
(25(OH)D ≥ 20 ng/ml), were significantly younger
(mean age = 39.3 and 44.2 vs. 49.6 years, p < 0.0001),
and had a higher BMI (mean BMI =30.4 and 30.1 vs.
28.3 kg/m2, p = 0.001) and a lower dietary intake of vita-
min D (median intake = 14.8 and 19.9 vs. 26.7 IU/day/
1,000 kcal, p = 0.02) and calcium (median = 296.8 and
319.2 vs. 368.8 mg/day/1,000 kcal, p = 0.004) (Table 1).
They were also more likely to be females (67.2 and 46.8
vs. 49.1 %, p < 0.0001) and nonsmokers (75.3 and 64.0 vs.
61.8 %, p = 0.005), and receive a higher level of education
(57.5 and 49.7 vs. 42.3 %, p < 0.0001), and were less likely
to be users of vitamin D (2.0 and 4.3 vs. 10.3 %, p = 0.001)
or calcium supplements (5.5 and 9.2 vs. 17.6 %, p < 0.0001),
and to have blood drawn during summer or fall season
(80.5 and 85.4 vs. 94.5 %, p = 0.0002). No significant differ-
ence in the level of physical activity was found by vitamin
D status.
About one-fourth (25.5 %) of the Kuwaiti adults had
diabetes and one-third (33.9 %) had prediabetes. Diabetic
and prediabetic participants, compared to nondiabetic
participants, were significantly older (54.7 and 45.5 vs.
34.6 years, p < 0.0001), had a higher BMI (31.5 and 31.1
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Table 1 Characteristics of Kuwaiti Adults by Vitamin D Status, NNSSK 2008–2009
Vitamin D status (Serum 25(OH)D)
Sufficient (≥20 ng/ml) (N = 165) Inadequate (12–19.9 ng/ml) (N = 447) Deficient (<12 ng/ml) (N = 348) P value
Age (year), mean (SD) 49.6 (15.2) 44.2 (14.5) 39.3 (12.7) <0.0001
Sex, N (%)
Male 84 (50.9) 238 (53.2) 114 (32.8) <0.0001
Female 81 (49.1) 209 (46.8) 234 (67.2)
Education, N (%)
Less than high school 70 (42.4) 146 (32.7) 76 (21.8) <0.0001
High school 17 (10.3) 79 (17.7) 72 (20.7)
College or higher 78 (42.3) 222 (49.7) 200 (57.5)
BMI (kg/m2), mean (SD) 28.3 (5.1) 30.1 (6.5) 30.4 (6.8) 0.001
N (%)
<25 44 (26.7) 91 (20.5) 70 (20.2) 0.01
25–29 67 (40.6) 149 (33.6) 105 (30.3)
≥30 54 (32.7) 204 (46.0) 172 (49.6)
Physical activitya, N (%)
Sedentary 140 (84.9) 367 (82.5) 297 (85.8) 0.42
Active 25 (15.2) 78 (17.5) 49 (14.2)
Smoking status, N (%)
Nonsmokers 102 (61.8) 286 (64.0) 262 (75.3) 0.005
Former smokers 24 (14.6) 63 (14.1) 35 (10.1)
Current smokers 39 (23.6) 98 (21.9) 51 (14.7)
Season of blood drawb, N (%)
Winter/Spring 9 (5.5) 64 (14.6) 66 (19.5) 0.0002
Summer/fall 155 (94.5) 374 (85.4) 273 (80.5)
Dietary intake of vitamin D (IU/day per 1,000 kcal)
Median (IQR) 26.7 (57.3) 19.9 (47.1) 14.8 (41.0) 0.02
N (%)
Low (<20.9) 195 (51.5) 171 (53.9) 137 (57.3) 0.02
High (≥20.9) 184 (48.5) 146 (46.1) 102 (42.7)
Supplemental use of vitamin D, N (%)
No 148 (89.7) 428 (95.8) 341 (98.0) 0.0001
Yes 17 (10.3) 19 (4.3) 7 (2.0)
Dietary intake of calcium (mg/day per 1,000 kcal)
Median (IQR) 368.8 (265.4) 319.2 (236.8) 296.8 (208.3) 0.0004
N(%)
Low (<348.2) 217 (55.9) 154 (47.5) 108 (44.4) 0.01
High (≥348.2) 171 (44.1) 170 (52.5) 135 (55.6)
Supplemental use of calcium, N (%)
No 136 (82.4) 406 (90.8) 329 (94.5) <0.0001
Yes 29 (17.6) 41 (9.2) 19 (5.5)
aA subject was defined as being physically active if having moderate physical activity ≥150 min/week or strenuous physical activity ≥75 min/week, and physically
inactive otherwise, according to the 2008 CDC physical activity guidelines [1]
bSpring and summer seasons were Feb.16-Nov.4, and fall and winter seasons were Nov.5–Feb.15
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vs. 27.9 kg/m2, p < 0.0001), and tended to have high diet-
ary intake of vitamin D (57.3 and 46.1 vs. 48.5 %, p = 0.02)
and calcium (55.6 and 52.5 vs. 44.1 %, p = 0.01). Diabetic
and prediabetic participants also had a lower percentage
of completing college education (35.3 and 54.9 vs. 60.3 %,
p < 0.0001) and were less likely to be physically activity
compared to nondiabetic participants (9.0 and 12.7 vs.
23.1 %, p < 0.0001) (Table 2).
After multivariate adjustment, serum concentration of
vitamin D was significantly lower in prediabetic and dia-
betic participants (39.6 and 39.8 ng/ml) than nondia-
betic participants (42.9 ng/ml, p = 0.01). When the
prevalences odds of prediabetes and diabetes were eval-
uated by vitamin D status in multinomial logistic regres-
sion models adjusting for age, vitamin D inadequacy
was associated with 70 % increased odds of prediabetes
(OR = 1.9, 95 % CI: 1.2–3.0), and vitamin D deficiency
was associated with two-fold increased odds of predia-
betes (OR = 2.1, 95 % CI: 1.3–3.5), and these associa-
tions were dose-dependent (P trend = 0.008). Additional
adjustment for education, body mass index, smoking
status, physical activity, dietary and supplemental use
of vitamin D and calcium, and season of blood draw
yielded similar results: vitamin D inadequacy was asso-
ciated with 70 % increased odds of prediabetes (OR =
1.7, 95 % CI: 1.0–2.9), and vitamin D deficiency was as-
sociated with two-fold increased odds of prediabetes
(OR = 2.0, 95 % CI: 1.1–3.3, P trend = 0.03). Vitamin D
inadequacy and vitamin D deficiency were also associ-
ated with two-fold increased odds of diabetes (OR =
2.1, 95 % CI: 1.2–3.7 and OR = 2.0, 95 % CI: 1.1–3.9,
respectively, P trend =0.06) (Table 3). Similarly, predia-
betes and diabetic participants were more likely to
have vitamin D inadequacy or deficiency compared to
nondiabetic participants (Additional file 1: Table S1).
Results from interaction analyses indicated that
participants who were deficient/inadequate in vita-
min D and overweight/obese had more than three-
fold increased odds of diabetes or prediabetes com-
pared to those who had sufficient vitamin D status
and were not overweight/obese (OR = 3.6, 95 % CI:
1.8–7.1). Participants who were nonusers of calcium
supplement when they were also deficient/inadequate
in vitamin D had nearly three-fold increased odds of
diabetes or prediabetes compared to those who were
sufficient in vitamin D and used calcium supplement
(OR = 2.8, 95 % CI:1.3–5.8). However, none of the
multiplicative interactions reached statistical signifi-
cance. Because only a small percentage of the partic-
ipants used vitamin D supplements, we were not
able to evaluate whether the associations differed by
supplemental use of vitamin D. Dietary intake of
vitamin D and calcium did not modify the associa-
tions (Additional file 1: Table S2).
Discussion
In a population in the Middle East where the prevalence
of diabetes has been rising markedly in the past decade,
we found vitamin D deficiency is highly prevalent in Ku-
waiti adults, and low vitamin D status was associated
with a high prevalence of diabetes.
Vitamin D status is often measured by serum levels of
25-hydroxyvitamin D (25(OH)D), the primary circulating
form of vitamin D. The Institute of Medicine (IOM) re-
leased new Dietary Reference Intakes in 2011 for calcium
and vitamin D [22], and defined vitamin D deficiency as
serum 25(OH)D <12 ng/ml and vitamin D inadequacy as
25(OH)D =12–19.9 ng/ml. These cut-off values are less
strict than the guidelines proposed by the Endocrine
Society, for which serum 25(OH)D <30 ng/ml is used to
categorize inadequate vitamin D status [28]. Although a
low vitamin D status has been reported in populations of
Middle East, our study is the first that reported vitamin D
status in a national representative sample. Our findings
suggested that Kuwaiti adults have an alarmingly low vita-
min D status, even based on the less strict IOM definition.
Nearly half of the Kuwaiti adults had vitamin D inad-
equacy (serum 25(OH)D =12–19.9 ng/ml) and more
than one-third had vitamin D deficiency (serum
25(OH)D < 12 ng/ml). These together suggest more
than 80 % of the Kuwaiti adults are at risk for inad-
equate vitamin D. This is in contrast to the findings
from the United States that about one-quarter of the US
population had vitamin D inadequacy and only 8 % were
at risk of vitamin D deficiency [29].
The low vitamin D status in Kuwaiti adults may result
from reduced exposure to sunshine and low dietary intake
of fortified products and dietary supplements. Sun expos-
ure represents the most import source of vitamin D pro-
duction in human body [30]. Although Kuwait is a
country with ample sunshine, the cultural practice of
clothing shields most skin from sunshine in particular in
women. In this national survey, we observed that vitamin
D status was much lower in women than in men. In
addition, fortification of dairy products with vitamin D is
not mandatory in Kuwait and the consumption of milk is
generally very low, possibly due to a high prevalence of
lactose intolerance [31]. Although participants who re-
ported the use of vitamin D supplements or had higher
dietary intake of vitamin D also had a higher level of
serum 25(OH)D, the overall dietary intake of vitamin D
was low (median = 21 IU/day per 1,000 kcal) and the use
of vitamin D supplement was uncommon (<5 %). More-
over, Kuwait is a country that has been experiencing a
marked increase in the prevalence of obesity in the past
decade, which can additionally contribute to a low vitamin
D status in Kuwaiti adults. These findings point to the
need of continuously monitoring vitamin D status in
Kuwaiti population and identifying contributing factors.
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Table 2 Characteristics of Kuwaiti Adults by Diabetes Status, NNSSK 2008-2009
Nondiabetic (N = 388) Prediabetica (N = 324) Diabetica (N = 244) P value
Age (yr),mean (SD) 34.6 (11.5) 45.5 (13.0) 54.7 (11.4) <0.0001
Sex, N (%)
Male 165 (42.5) 148 (46.0) 122 (50.0)
Female 223 (57.5) 175 (54.0) 122 (50.0) 0.18
Education, N (%)
Less than high school 78 (20.1) 91 (28.1) 122 (50.0)
High school 76 (19.6) 55 (17.0) 36 (14.7)
College or higher 234 (60.3) 178 (54.9) 86 (35.3) <0.0001
BMI (kg/m2), mean (SD) 27.9 (6.3) 31.1 (6.5) 31.5 (5.7) <0.0001
N (%)
<25 130 (33.7) 48 (14.9) 27 (11.1)
25–29 145 (37.6) 102 (31.6) 73 (30.0)
≥30 111 (28.8) 173 (53.5) 143 (58.9) <0.0001
Physical activityb, N (%)
Sedentary 296 (76.9) 282 (87.3) 222 (91.0)
Active 89 (23.1) 41 (12.7) 22 (9.0) <0.0001
Smoking status, N (%)
Nonsmokers 264 (68.0) 218 (67.3) 164 (67.2)
Former smokers 35 (9.0) 44 (13.6) 43 (17.6)
Current smokers 89 (22.9) 62 (19.1) 37 (15.2) 0.01
Season of blood drawc, N (%)
Winter/Spring 201 (51.8) 192 (59.3) 135 (55.6)
Summer/fall 187 (48.2) 132 (40.7) 108 (44.4) 0.14
Dietary intake of vitamin D, IU/day per 1,000 kcal
Median (IQR) 17.2 (43.7) 16.4 (41.8) 26.2 (57.1) 0.04
N (%)
Low (<20.9) 195 (51.5) 171 (53.9) 102 (42.7)
High (≥20.9) 184 (48.5) 146 (46.1) 137 (57.3) 0.02
Supplemental use of vitamin D, N (%)
No 375 (96.7) 305 (94.1) 233 (95.5)
Yes 13 (3.4) 19 (5.9) 11 (4.5) 0.27
Dietary intake of calcium, mg/day per 1,000 kcal
Median (IQR) 303.1 (216.3) 328.5 (230.3) 357.7 (259.8) 0.003
N (%)
Low (<348.2) 217 (55.9) 154 (47.5) 108 (44.4)
High (≥348.2) 171 (44.1) 170 (52.5) 135 (55.6) 0.01
Supplemental use of calcium, N (%)
No 356 (91.8) 294 (90.7) 218 (89.3)
Yes 32 (8.3) 30 (9.3) 26 (10.7) 0.59
aAccording to the American Diabetes Association’s criteria for the diagnosis of diabetes [2], a subject was defined as having diabetes if fasting glucose ≥7.0 mmol/L or
HbA1c ≥ 6.5 %, or if he/she reported a physician diagnosis of diabetes or use of medications to control diabetes. A subject was defined as having prediabetes if fasting
glucose = 5.6–6.9 mmol/L or HbA1c = 5.7–6.4 %
bA subject was defined as being physically active if having moderate physical activity ≥150 min/week or strenuous physical activity ≥75 min/week, and physically
inactive otherwise, according to the 2008 CDC physical activity guidelines [1]
cSpring and summer seasons were Feb.16–Nov.4, and fall and winter seasons were Nov.5-Feb.15
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Interestingly, we observed an advanced age was associ-
ated with high vitamin D status in this population. It has
to be noted that the adult population in Kuwait are rela-
tively young with a mean age of 43.6 years. Further in-
vestigations revealed that older participants were more
likely to donate blood in summer/fall seasons when
serum 25(OH) was high, and have an overall higher in-
take of vitamin D from food and supplement than youn-
ger participants, which may explain the higher vitamin
D status in older adults in Kuwait. Age is also a signifi-
cant risk factor for diabetes and thus a strong con-
founder for the association between vitamin D status
and prevalence of diabetes. In univariate analysis, a
higher prevalence of diabetes was observed in partici-
pants with sufficient or inadequate vitamin D status as
compared to those deficient in vitamin D. However, ad-
justment of age revealed the opposite. This is explained
by the fact that age served as a negative confounder, i.e.
advanced age was negatively associated with vitamin D
deficiency but positively with diabetes risk (i.e. a negative
confounder) [32]. Therefore, it is essential to adjust the
effect of age using multivariate analysis when evaluating
vitamin D status and diabetes (potentially other health
outcomes) in this population.
Low vitamin D status has been associated with an in-
creased risk of diabetes in populations of North America
and Europe [33]. Our results suggest that low vitamin D
status is also strongly associated with a high prevalence of
diabetes in a Middle East population. The possible mecha-
nisms for this association may include the presence of
vitamin D receptors in pancreatic beta cells to which cir-
culating vitamin D binds [34]. Vitamin D has been well
recognized for its role in regulating extracellular calcium
flux, and insulin secretion is known as a calcium
dependent process [35]. Several studies reported an im-
paired insulin release in association with vitamin D defi-
ciency [11, 36, 37], and vitamin D supplementation has
been shown to improve insulin release in randomized
controlled trials [38–40]. In addition, vitamin D has been
proposed to improve insulin resistance by stimulating the
expression of insulin receptors [12]. Vitamin D deficiency
has been linked to insulin resistance, and an improve-
ment of insulin action has been observed after vitamin
D supplementation [9, 41]. In addition, vitamin D may
improve insulin sensitivity by reducing systematic in-
flammation [42].
Our study has limitations. First, this investigation is
cross-sectional, which precludes any causal inference be-
ing made on vitamin D status and risk of diabetes. A re-
cent meta-analysis of 11 prospective cohort studies
involving a total of 3,612 cases reported a 70 % increased
risk of type 2 diabetes in association with vitamin D in-
sufficiency [33], but two randomized controlled trials
(RCTs) fail to support vitamin D supplementation pre-
vents diabetes [43, 44]. It is important to note that both
trials were conducted in populations where vitamin D
deficiency was uncommon. When the benefits from vita-
min D supplementation are confined to individuals with
vitamin D deficiency, RCTs will not be able to demon-
strate additional benefits from supplementation to those
with optimal levels [45]. Future longitudinal studies in-
cluding intervention trials are needed to further eluci-
date the association between vitamin D and diabetes, in
particular in populations where vitamin D deficiency is
prevalent. Second, vitamin D status was assessed by a
single measurement of serum 25(OH)D and can poten-
tially result in misclassification of subjects’ long-term
vitamin D status. However, a recent study that analyzed
serum 25(OH)D from the same individual at baseline,
year-1 and year-5 observed relatively low within-subject
variability and fairly high correlations in serum
25(OH)D measured at the three time points, suggesting
serum 25(OH)D is reasonably stable over a long period
of time [46]. When misclassification of vitamin D status
using a single measurement is present, it is likely to be
non-differential, which will result in bias towards the
null. The true association would be even stronger than
what was observed. Third, several demographic and
Table 3 Association between Serum 25(OH)D and Prevalence of Diabetes and Prediabetes in Kuwaiti Adults, NNSSK 2008-2009a
Nondiabetic Prediabetic OR (95 % CI) Diabetic OR (95 % CI)b
N (%) N (%) Model Ib Model IIc N (%) Model Ib Model IIc
Vitamin D Status
Sufficiency (25(OH)D≥ 20 ng/ml) 66 (40.2) 50 (30.5) 1.0 1.0 48 (29.3) 1.0 1.0
Inadequacy (25(OH)D =12–19.9 ng/ml) 167 (37.4) 149 (33.3) 1.9 (1.2–3.0) 1.7 (1.0–2.9) 131 (29.3) 2.4 (2.4–4.2) 2.1 (1.2–3.7)
Deficiency (25 (OH)D <12 ng/ml) 155 (44.9) 125 (36.2) 2.1 (1.3–3.5) 2.0 (1.1–3.3) 65 (18.8) 2.1 (1.2–3.8) 2.0 (1.1–3.9)
P trend = 0.008 P trend = 0.03 P trend = 0.046 P trend = 0.06
aAccording to the American Diabetes Association’s criteria for the diagnosis of diabetes [2], a subject was defined as having diabetes if fasting glucose ≥7.0 mmol/L or
HbA1c ≥ 6.5 %, and having prediabetes if fasting glucose = 5.6–6.9 mmol/L or HbA1c = 5.7–6.4 %
bModel I: Odds ratios (ORs) and 95 % confidence intervals (CIs) were adjusted for age
cModel II: Odds ratios (ORs) and 95 % confidence intervals (CIs) were additionally adjusted for sex, education (less than high school, high school, and college or
higher), body mass index (continuous), smoking status (current, former, and nonsmokers), physical activity (active vs. sedentary), dietary intake of vitamin D and
calcium (high vs. low according to median), supplemental intake of vitamin D and calcium (yes vs. no), and season of blood draw (summer/spring vs. winter/fall)
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behavior risks are associated with both vitamin D status
and diabetes risk. Although we adjusted a variety of con-
founders in our analyses, the possibility of residual con-
founding cannot be ruled out which can either over- or
under-estimate the results. Fourth, the survey did not
distinguish between type I or type II diabetes although
previous studies demonstrated vitamin D can affect both
type I diabetes through its immunomodulatory effect
[47] and type II diabetes through anti-inflammatory
effect [48]. Last, as with any study, our results may be
sensitive to bias from non-participation given that not
all eligible households participated in the survey. How-
ever, sampling weights were adjusted in all analyses to
account for the complex survey design including non-
participation.
Conclusions
In a national representative sample of Kuwaiti adults
that suffer from a rising incidence of diabetes, we found
an alarmingly high prevalence of vitamin D deficiency,
and low vitamin D status, is associated with a high
prevalence of diabetes. This calls for further investigating
the health consequences of low vitamin D status, i.e.
serum 25 (OH)D <20 ng/ml in Kuwait and other Middle
East countries, and the potential of improving vitamin D
status to prevent diabetes at the population level. Given
the high prevalence of diabetes and vitamin D deficiency
in Kuwaiti adults, improving vitamin D status, even to a
small extent, can potentially have a large impact on dia-
betes prevention in this high-risk population.
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